NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has settled with Genesis Genetics Institute over GTG's patent covering its non-coding DNA technology.

GTG sued Detroit-based Genesis Genetics in September in US District Court Eastern District of Michigan, Southern Division, alleging Genesis Genetics infringed on US Patent No. 5,612,179 which was assigned by an entity called Genetype AG to GTG.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.